Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Endo Int'l Plc (ENDP)

Endo Int'l Plc (ENDP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 787,114
  • Shares Outstanding, K 226,834
  • Annual Sales, $ 2,914 M
  • Annual Income, $ -422,640 K
  • 60-Month Beta 1.30
  • Price/Sales 0.29
  • Price/Cash Flow 0.72
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 0.51
  • Number of Estimates 7
  • High Estimate 0.55
  • Low Estimate 0.47
  • Prior Year 0.53
  • Growth Rate Est. (year over year) -3.77%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.08 +66.83%
on 03/18/20
5.77 -39.86%
on 03/03/20
-2.16 (-38.37%)
since 02/27/20
3-Month
2.08 +66.83%
on 03/18/20
7.10 -51.13%
on 02/25/20
-0.98 (-22.02%)
since 12/27/19
52-Week
1.97 +76.14%
on 09/05/19
8.55 -59.42%
on 05/09/19
-4.68 (-57.42%)
since 03/27/19

Most Recent Stories

More News
Approval of Settlement of Canadian AMS Women's Pelvic Mesh Litigation

Siskinds LLP, Siskinds, Desmeules s.e.n.c.r.l., Rochon Genova LLP, and Merchant Law Group announced today court approval of a Canada-wide settlement reached in two class actions related to certain women's...

ENDP : 3.47 (-7.96%)
MDSY : 0.73 (+4.29%)
Why Is Endo (ENDP) Down 33% Since Last Earnings Report?

Endo (ENDP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ENDP : 3.47 (-7.96%)
BioDelivery (BDSI) Q4 Earnings and Revenues Beat Estimates

BioDelivery (BDSI) beats earnings and sales expectations for the fourth quarter of 2019.

ENDP : 3.47 (-7.96%)
REGN : 449.52 (-0.61%)
VRTX : 217.24 (-3.23%)
BDSI : 3.53 (+0.57%)
Mallinckrodt Up on New York's Support for Opioid Settlement

Mallinckrodt's (MNK) proposed global opioid settlement receives support from New York State Attorney General, taking the total support count to 48 states and territories.

ENDP : 3.47 (-7.96%)
JNJ : 123.16 (-2.69%)
TEVA : 7.56 (-4.30%)
MNK : 2.23 (-3.88%)
Implied Volatility Surging for Endo International (ENDP) Stock Options

Investors need to pay close attention to Endo International (ENDP) stock based on the movements in the options market lately.

ENDP : 3.47 (-7.96%)
Endo's (ENDP) Earnings & Revenues Trump Estimates in Q4

Endo (ENDP) earnings and sales beat estimates in the fourth quarter but witness year-over-year declines.

ENDP : 3.47 (-7.96%)
JNJ : 123.16 (-2.69%)
TEVA : 7.56 (-4.30%)
MNK : 2.23 (-3.88%)
First Week of ENDP October 16th Options Trading

Investors in Endo International plc saw new options become available this week, for the October 16th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the...

ENDP : 3.47 (-7.96%)
Endo International Reaches Analyst Target Price

In recent trading, shares of Endo International plc have crossed above the average analyst 12-month target price of $6.42, changing hands for $6.53/share. When a stock reaches the target an analyst has...

ENDP : 3.47 (-7.96%)
Global Opioids Market (2019 to 2026) - Featuring Allergan, Boehringer Ingelheim Group and Endo Pharmaceuticals Among Others - ResearchAndMarkets.com

The "Opioids Market by Product and Application: Global Opportunity Analysis and Industry Forecast, 2019-2026" report has been added to ResearchAndMarkets.com's offering.

AGN : 173.00 (-1.45%)
ENDP : 3.47 (-7.96%)
Endo International (ENDP) Q4 Earnings and Revenues Top Estimates

Endo (ENDP) delivered earnings and revenue surprises of 29.82% and 5.25%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

ENDP : 3.47 (-7.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Trade ENDP with:

Business Summary

Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova,...

See More

Key Turning Points

2nd Resistance Point 3.73
1st Resistance Point 3.60
Last Price 3.47
1st Support Level 3.37
2nd Support Level 3.27

See More

52-Week High 8.55
Fibonacci 61.8% 6.04
Fibonacci 50% 5.26
Fibonacci 38.2% 4.48
Last Price 3.47
52-Week Low 1.97

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar